To conduct basic and applied research on biological threats resulting in medical solutions to protect the warfighter.
To be the Nation's preeminent research laboratory providing cutting-edge medical research for the warfighter against biological threats.
- To ensure that research is conducted in a safe and secure environment.
- To preserve and enhance USAMRIID’s ability to conduct basic and applied medical research in support of warfighter needs.
- To deliver competitive products to the advanced developer on schedule with the best value and quality.
- To promote a dynamic and intellectually stimulating environment that allows for personal and professional growth and a superior quality of life.
USAMRIID,
(Fort Detrick, Maryland) conducts basic and applied research
on biological threats resulting in medical solutions to protect military
service members.
USAMRIID, an organization of the U.S. Army Medical Research and Materiel Command,
is the lead medical research laboratory for the U.S. Biological Defense Research
Program. The Institute plays a key role as the only laboratory
in the Department of Defense (DoD) equipped to safely study highly hazardous
infectious agents requiring maximum containment at biosafety level (BSL)-4.
As the center of excellence for DoD medical biological defense research, USAMRIID’s
challenge is to maintain its world-class scientific and technology base while
being responsive to its primary customer—the warfighter.
* This document is
a PDF file and requires that Adobe Acrobat Reader is installed on your
computer. If you already
have this program, you may begin browsing the documents. If you do not
have this program, click on the link below to install it on your computer: http://www.adobe.com/products/acrobat/readstep2.html.
Home • About
USAMRIID • USAMRIID
Highlights Over the Years • Publications
Library
Business
Opportunities • Employment • Education & Training • Reference
Materials
Related
Links • Newsroom • Contact
Us
Please read this external links disclaimer.
Last updated: 15 April, 2004
